Cre recombinase: The universal reagent for genome tailoring

Genesis

Volumn 26, Issue 2, 2000, Pages 99-109

  Nagy, Andras ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; RECOMBINASE; UNCLASSIFIED DRUG;

ALLELE; ANIMAL TISSUE; DNA REPAIR; GENE ACTIVATION; GENE TARGETING; GENETIC RECOMBINATION; KNOCKOUT GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN FAMILY; REVIEW; TRANSGENE;

ANIMALS; GENOME; INTEGRASES; MICE; MICE, TRANSGENIC; VIRAL PROTEINS;

ANIMALIA;

EID: 0034059140     PISSN: 1526954X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B     Document Type: Review

References (48)

1. Abuin A, Bradley A. 1996. Recycling selectable markers in mouse embryonic stem cells. Mol Cell Biol 16:1851-1856.
2. Araki K, Araki M, Miyazaki J, Vassalli P. 1995. Site-specific recombination of a transgene in fertilized eggs by transient expression of Cre recombinase. Proc Natl Acad Sci USA 92:160-164.
3. Araki K, Araki M, Yamamura K. 1997. Targeted integration of DNA using mutant lox sites in embryonic stem cells. Nucleic Acids Res 25:868-872.
4. Araki K, Imaizumi T, Sekimoto T, Yoshinobu K, Yoshimuta J, Akizuki M, Miura K, Araki M, Yamamura K. 1999. Exchangeable gene trap using the Cre/mutated lox system [In Process Citation]. Cell Mol Biol (Noisy-Le-Grand) 45:737-750.
5. Betz UA, Vosshenrich CA, Rajewsky K, Muller W. 1996. Bypass of lethality with mosaic mice generated by Cre-loxP-mediated recombination. Curr Biol 6:1307-1316.
6. Brocard J, Feil R, Chambon P, Metzger D. 1998. A chimeric Cre recombinase inducible by synthetic, but not by natural ligands of the glucocorticoid receptor. Nucleic Acids Res 26:4086-4090.
7. Buchholz F, Angrand PO, Stewart AF. 1998. Improved properties of FLP recombinase evolved by cycling mutagenesis [see comments]. Nat Biotechnol 16:657-662.
8. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439.
9. Danielian PS, Muccino D, Rowitch DH, Michael SK, McMahon AP. 1998. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr Biol 8:1323-1326.
10. Dymecki SM, Tomasiewicz H. 1998. Using Flp-recombinase to characterize expansion of Wnt1-expressing neural progenitors in the mouse. Dev Biol 201:57-65.
11. Fiering S, Epner E, Robinson K, Zhuang Y, Telling A, Hu M, Martin DI, Enver T, Ley TJ, Groudine M. 1995. Targeted deletion of 5′HS2 of the murine beta-globin LCR reveals that it is not essential for proper regulation of the beta-globin locus. Genes Dev 9:2203-2213.
12. Gu H, Marth JD, Orban PC, Mossmann H, Rajewsky K. 1994. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting [see comments]. Science 265:103-106.
13. Gu H, Zou YR, Rajewsky K. 1993. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 73:1155-1164.
14. Hadjantonakis AK, Gertsenstein M, Ikawa M, Okabe M, Nagy A. 1998. Generating green fluorescent mice by germline transmission of green fluorescent ES cells. Mech Dev 76:79-90.
15. Hamilton DL, Abremski K. 1984. Site-specific recombination by the bactericphage P1 lox-Cre system. Cre-mediated synapsis of two lox sites. J Mol Biol 178:481-486.
16. Holland EC, Hively WP, DePinho RA, Varmus HE. 1998. A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. Genes Dev 12:3675-3685.
17. Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA. 1994. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet 7:353-361.
18. Kellendonk C, Troche F, Casanova E, Anlag K, Opherk C, Schutz G. 1999. Inducible site-specific recombination in the brain. J Mol Biol 285:175-182.
19. Lakso M, Sauer B, Mosinger B Jr., Lee EJ, Manning RW, Yu SH, Mulder KL, Westphal H. 1992. Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci USA 89:6232-6236.
20. Lallemand Y, Luria V, Haffner-Krausz R, Lonai P. 1998. Maternally expressed PGK-Cre transgene as a tool for early and uniform activation of the Cre site-specific recombinase. Transgenic Res 7:105-112.
21. Lewandoski M, Martin GR. 1997. Cre-mediated chromosome loss in mice. Nat Genet 17:223-225.
22. Lobe CG, Koop KE, Kreppner W, Lomeli H, Gertsenstein M, Nagy A. 1999. Z/AP, a double reporter for Cre-mediated recombination. Dev Biol 208:281-292.
23. Lobe CG, Nagy A. 1998. Conditional genome alteration in mice. Bioessays 20:200-208.
24. Mao X, Fujiwara Y, Orkin SH. 1999. Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice. Proc Natl Acad Sci USA 96:5037-5042.
25. Meyers EN, Lewandoski M, Martin GR. 1998. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat Genet 18:136-141.
26. Nagy A. 1996. Engineering the mouse genome. In: Lonai P, editor. Mammalian development Amsterdam: Harwood Academic Publishers. p 339-371.
27. Nagy A, Moens CB, Ivanyi E, Pawling J, Gertsenstein M, Hadjantonakis A-K, Pirity M, Rossant J. 1998. Dissecting the role of N-myc in development using a single targeting vector to generate a series of alleles. Curr Biol 8:In press.
28. Nagy A, Rossant J. 1996. Targeted mutagenesis: analysis of phenotype without germ line transmission. J Clin Invest 97:1360-1365.
29. Niwa H, Yamamura K, Miyazaki J. 1991. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193-199.
30. Orban PC, Chui D, Marth JD. 1992. Tissue- and site-specific DNA recombination in transgenic mice. Proc Natl Acad Sci USA 89: 6861-6865.
31. Ramirez-Solis R, Liu P, Bradley A. 1995. Chromosome engineering in mice. Nature 378:720-724.
32. Reichardt HM, Kaestner KH, Wessely O, Gass P, Schmid W, Schutz G. 1998. Analysis of glucocorticoid signalling by gene targeting. J Steroid Biochem Mol Biol 65:111-115.
33. Rossant J, McMahon A. 1999. "Cre"-ating mouse mutants - a meeting review on conditional mouse genetics. Genes Dev 13:142-145.
34. Rossant J, Nagy A. 1995. Genome engineering: the new mouse genetics. Nat Med 1:592-594.
35. Rossant J, Spence A. 1998. Chimeras and mosaics in mouse mutant analysis. Trends Genet 14:358-363.
36. Sakai K, Miyazaki J. 1997. A transgenic mouse line that retains Cre recombinase activity in mature oocytes irrespective of the Cre transgene transmission. Biochem Biophys Res Commun 237:318-324.
37. Sauer B, Henderson N. 1988. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc Natl Acad Sci USA 85:5166-5170.
38. Sauer B. Henderson N. 1989. Cre-stimulated recombination at loxP-containing DNA sequences placed into the mammalian genome. Nucleic Acids Res 17:147-161.
39. Sauer B, Henderson N. 1990. Targeted insertion of exogenous DNA into the eukaryotic genome by the Cre recombinase. New Biol 2:441-449.
40. Smith AJ, De Sousa MA, Kwabi-Addo B, Heppell-Parton A, Impey H, Rabbitts P. 1995. A site-directed chromosomal translocation induced in embryonic stem cells by Cre-loxP recombination [published erratum appears in Nat Genet 1996 Jan;12(1):110]. Nat Genet 9:376-385.
41. Soriano P. 1999. Generalized lacZ expression with the ROSA26 Cre reporter strain [letter]. Nat Genet 21:70-71.
42. Soukharev S, Miller JL, Sauer B. 1999. Segmental genomic replacement in embryonic stem cells by double lox targeting. Nucleic Acids Res 27:e21.
43. Takeda K, Kaisho T, Yoshida N, Takeda J, Kishimoto T, Akira S. 1998. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J Immunol 161:4652-4660.
44. Tsien JZ, Chen DF, Gerber D, Tom C, Mercer EH, Anderson DJ, Mayford M, Kandel ER, Tonegawa S. 1996. Subregion- and cell type-restricted gene knockout in mouse brain. Cell 87:1317-1326.
45. Tybulewicz VL, Crawford CE, Jackson PK, Bronson RT, Mulligan RC. 1991. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65:1153-1163.
46. Voziyanov Y, Pathania S, Jayaram M. 1999. A general model for site-specific recombination by the integrase family recombinases. Nucleic Acids Res 27:930-941.
47. Wang Y, Spatz MK, Kannan K, Hayk H, Avivi A, Gorivodsky M, Pines M, Yayon A, Lonai P, Givol D. 1999. A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3. Proc Natl Acad Sci USA 96:4455-4460.
48. Zheng B, Sage M, Cai WW, Thompson DM, Tavsanli BC, Cheah YC, Bradley A. 1999. Engineering a mouse balancer chromosome. Nat Genet 22:375-378.